Kernel
@kernelneuro.bsky.social
🧠 Unmatched neurotechnology making brain health measurable, actionable, and accessible — through world-class hardware, software, and science.
Our CEO will be at @onemindorg.bsky.social's workshop - Frontiers in Neuroengineering and Psychiatry: Translating Research and Innovation into Real World Impact (@embs.org)
Join to hear him chat with Sam Tabone and @arianetom.bsky.social about company creation in the #neuropsychiatry space.
Join to hear him chat with Sam Tabone and @arianetom.bsky.social about company creation in the #neuropsychiatry space.
November 4, 2025 at 6:10 PM
Our CEO will be at @onemindorg.bsky.social's workshop - Frontiers in Neuroengineering and Psychiatry: Translating Research and Innovation into Real World Impact (@embs.org)
Join to hear him chat with Sam Tabone and @arianetom.bsky.social about company creation in the #neuropsychiatry space.
Join to hear him chat with Sam Tabone and @arianetom.bsky.social about company creation in the #neuropsychiatry space.
🗣️ #Neurotech Leaders Forum is coming up! Join moderator @jojoplatt.bsky.social (Neurotech Reports) & panelists Ryan Field (Kernel), Christian Howell (Cognito Therapeutics) & Kazu Okuda (Universal Brain) as they examine the market potential for consumer neurotech and digital health.
11/6 @ 11:15am
11/6 @ 11:15am
October 31, 2025 at 5:04 PM
🗣️ #Neurotech Leaders Forum is coming up! Join moderator @jojoplatt.bsky.social (Neurotech Reports) & panelists Ryan Field (Kernel), Christian Howell (Cognito Therapeutics) & Kazu Okuda (Universal Brain) as they examine the market potential for consumer neurotech and digital health.
11/6 @ 11:15am
11/6 @ 11:15am
📄 We are sharing our work at @cnssummit.bsky.social in Boston next week! If you plan to attend, don’t miss our poster – Developing a brain-based metric of depression severity using portable brain measurement.
October 29, 2025 at 5:05 PM
📄 We are sharing our work at @cnssummit.bsky.social in Boston next week! If you plan to attend, don’t miss our poster – Developing a brain-based metric of depression severity using portable brain measurement.
🧠 Attending #HLTHUSA next week? Schedule your Brain Age scan here: calendar.app.google/QrLNFit2vmyZ...
#brainhealth #cognition #neuroscience
#brainhealth #cognition #neuroscience
October 17, 2025 at 5:17 PM
🧠 Attending #HLTHUSA next week? Schedule your Brain Age scan here: calendar.app.google/QrLNFit2vmyZ...
#brainhealth #cognition #neuroscience
#brainhealth #cognition #neuroscience
👀 Kernel’s latest newsletter is out, covering some exciting updates and our latest product launch! www.kernel.com/newsletter/2...
Want to receive future updates in your inbox? Subscribe here: www.kernel.com/contact#news...
Want to receive future updates in your inbox? Subscribe here: www.kernel.com/contact#news...
October 8, 2025 at 5:07 PM
👀 Kernel’s latest newsletter is out, covering some exciting updates and our latest product launch! www.kernel.com/newsletter/2...
Want to receive future updates in your inbox? Subscribe here: www.kernel.com/contact#news...
Want to receive future updates in your inbox? Subscribe here: www.kernel.com/contact#news...
It's officially fall and Kernel is on the move! First stop: Amsterdam for the #ISCTM Autumn Conference.
You can find our CEO, Ryan Field, at the poster session & reception on Oct. 10 from 6:00 - 7:30 p.m. presenting our latest work on #depression severity monitoring in #clinicaltrials.
You can find our CEO, Ryan Field, at the poster session & reception on Oct. 10 from 6:00 - 7:30 p.m. presenting our latest work on #depression severity monitoring in #clinicaltrials.
October 3, 2025 at 5:34 PM
It's officially fall and Kernel is on the move! First stop: Amsterdam for the #ISCTM Autumn Conference.
You can find our CEO, Ryan Field, at the poster session & reception on Oct. 10 from 6:00 - 7:30 p.m. presenting our latest work on #depression severity monitoring in #clinicaltrials.
You can find our CEO, Ryan Field, at the poster session & reception on Oct. 10 from 6:00 - 7:30 p.m. presenting our latest work on #depression severity monitoring in #clinicaltrials.
🌎 Kernel is proud to sponsor the third edition of the Neuroscience of the Everyday World Conference, hosted by @bostonu.bsky.social and @cheninstitute.bsky.social.
🧠 Tune in to hear Katherine Perdue on the Neurotechnology Panel – Monday, July 28th at 2:00 p.m. EDT.
🧠 Tune in to hear Katherine Perdue on the Neurotechnology Panel – Monday, July 28th at 2:00 p.m. EDT.
July 25, 2025 at 7:50 PM
🌎 Kernel is proud to sponsor the third edition of the Neuroscience of the Everyday World Conference, hosted by @bostonu.bsky.social and @cheninstitute.bsky.social.
🧠 Tune in to hear Katherine Perdue on the Neurotechnology Panel – Monday, July 28th at 2:00 p.m. EDT.
🧠 Tune in to hear Katherine Perdue on the Neurotechnology Panel – Monday, July 28th at 2:00 p.m. EDT.
✍️ Kernel just published a study in NPJ Dementia (@natureportfolio.nature.com) demonstrating the ability to distinguish MCI patients from healthy age-matched controls.
Using 15 minutes of brain scans, behavioral data, and a short survey, we were able to classify MCI with an AUC=0.92!
Using 15 minutes of brain scans, behavioral data, and a short survey, we were able to classify MCI with an AUC=0.92!
July 8, 2025 at 4:28 PM
✍️ Kernel just published a study in NPJ Dementia (@natureportfolio.nature.com) demonstrating the ability to distinguish MCI patients from healthy age-matched controls.
Using 15 minutes of brain scans, behavioral data, and a short survey, we were able to classify MCI with an AUC=0.92!
Using 15 minutes of brain scans, behavioral data, and a short survey, we were able to classify MCI with an AUC=0.92!
If you missed Kernel's latest poster at #SOBP2025 last month, you have a chance to catch it at #APAAM25 this month!
🧠 Developing a Treatment Decision-Making Aid for Major Depressive Disorder Using Functional Brain Measures
📅 Sat 5/17 1:30-3pm
📍 Exhibit Hall, LACC
@apapsychiatric.bsky.social
🧠 Developing a Treatment Decision-Making Aid for Major Depressive Disorder Using Functional Brain Measures
📅 Sat 5/17 1:30-3pm
📍 Exhibit Hall, LACC
@apapsychiatric.bsky.social
May 12, 2025 at 11:05 PM
If you missed Kernel's latest poster at #SOBP2025 last month, you have a chance to catch it at #APAAM25 this month!
🧠 Developing a Treatment Decision-Making Aid for Major Depressive Disorder Using Functional Brain Measures
📅 Sat 5/17 1:30-3pm
📍 Exhibit Hall, LACC
@apapsychiatric.bsky.social
🧠 Developing a Treatment Decision-Making Aid for Major Depressive Disorder Using Functional Brain Measures
📅 Sat 5/17 1:30-3pm
📍 Exhibit Hall, LACC
@apapsychiatric.bsky.social
🇨🇦 If you’re planning to be in Toronto for the #SOBP2025 annual meeting, be sure to stop by Kernel’s poster session!
🧠 We will be presenting the results of our PREDICT study (Prediction of REsponse to #Depression Interventions Using Clinical and TD-fNIRS Measurements).
🧠 We will be presenting the results of our PREDICT study (Prediction of REsponse to #Depression Interventions Using Clinical and TD-fNIRS Measurements).
April 15, 2025 at 4:22 PM
🇨🇦 If you’re planning to be in Toronto for the #SOBP2025 annual meeting, be sure to stop by Kernel’s poster session!
🧠 We will be presenting the results of our PREDICT study (Prediction of REsponse to #Depression Interventions Using Clinical and TD-fNIRS Measurements).
🧠 We will be presenting the results of our PREDICT study (Prediction of REsponse to #Depression Interventions Using Clinical and TD-fNIRS Measurements).
✍️ Kernel published a study in Imaging Neuroscience from @mitpress.bsky.social that describes our Flow2 technology for measuring cortical brain metrics. The combination of good system performance, low cost, and easy-to-use form factor of Flow2 is unprecedented.
direct.mit.edu/imag/article...
direct.mit.edu/imag/article...
February 25, 2025 at 10:46 PM
✍️ Kernel published a study in Imaging Neuroscience from @mitpress.bsky.social that describes our Flow2 technology for measuring cortical brain metrics. The combination of good system performance, low cost, and easy-to-use form factor of Flow2 is unprecedented.
direct.mit.edu/imag/article...
direct.mit.edu/imag/article...
February 20, 2025 at 7:27 PM
ICYMI: Kernel’s Q3 Recap
🧠 Read here → www.kernel.com/newsletter/2...
📥 Subscribe here → www.kernel.com#newsletter
🧠 Read here → www.kernel.com/newsletter/2...
📥 Subscribe here → www.kernel.com#newsletter
November 21, 2024 at 8:11 PM
ICYMI: Kernel’s Q3 Recap
🧠 Read here → www.kernel.com/newsletter/2...
📥 Subscribe here → www.kernel.com#newsletter
🧠 Read here → www.kernel.com/newsletter/2...
📥 Subscribe here → www.kernel.com#newsletter
Moving forward, we hope this approach can be used to help patients with MCI get the care they need to preserve their cognition by providing quantitative and timely assessments of brain functioning. Early identification of MCI will support the fight to end Alzheimer's! #ENDALZ
November 19, 2024 at 12:00 AM
Moving forward, we hope this approach can be used to help patients with MCI get the care they need to preserve their cognition by providing quantitative and timely assessments of brain functioning. Early identification of MCI will support the fight to end Alzheimer's! #ENDALZ
Our machine learning model for classifying if an individual is likely to have MCI had excellent performance with 85% accuracy, 80% sensitivity and 90% specificity. This is better performance than current standard screening tools used in clinical practice.
November 18, 2024 at 11:59 PM
Our machine learning model for classifying if an individual is likely to have MCI had excellent performance with 85% accuracy, 80% sensitivity and 90% specificity. This is better performance than current standard screening tools used in clinical practice.
We combine patterns of brain activation with the task performance and a simple questionnaire into a machine learning model that classifies subjects as either being healthy or having MCI.
November 18, 2024 at 11:59 PM
We combine patterns of brain activation with the task performance and a simple questionnaire into a machine learning model that classifies subjects as either being healthy or having MCI.
However, to be clinically relevant, we need to be looking at individuals and not groups. This is where machine learning comes in!
November 18, 2024 at 11:58 PM
However, to be clinically relevant, we need to be looking at individuals and not groups. This is where machine learning comes in!
We also found that there were differences in brain activity between the two groups during both the memory (a) and language (b) challenges. Red regions indicate more brain activity in the HC group while blue indicates more in the MCI group.
November 18, 2024 at 11:58 PM
We also found that there were differences in brain activity between the two groups during both the memory (a) and language (b) challenges. Red regions indicate more brain activity in the HC group while blue indicates more in the MCI group.
We found for both the memory and language challenges, performance was different between the MCI and HC groups. This makes sense because cognitive testing performance is commonly used to diagnose MCI.
November 18, 2024 at 11:57 PM
We found for both the memory and language challenges, performance was different between the MCI and HC groups. This makes sense because cognitive testing performance is commonly used to diagnose MCI.
In our study, MCI patients (MCI, n=50) and age-matched healthy controls (HC, n=51) completed language and memory cognitive tasks while their brains were measured with the Flow2 TD-fNIRS system. This is similar to a stress test for the brain that takes about <15 minutes.
November 18, 2024 at 11:56 PM
In our study, MCI patients (MCI, n=50) and age-matched healthy controls (HC, n=51) completed language and memory cognitive tasks while their brains were measured with the Flow2 TD-fNIRS system. This is similar to a stress test for the brain that takes about <15 minutes.
Mild cognitive impairment (MCI) affects a large and growing number of Americans, and most are not diagnosed. Missed diagnoses rob patients of the opportunity to preserve their cognition and delay progression to dementia. How can we identify these patients earlier?
November 18, 2024 at 11:56 PM
Mild cognitive impairment (MCI) affects a large and growing number of Americans, and most are not diagnosed. Missed diagnoses rob patients of the opportunity to preserve their cognition and delay progression to dementia. How can we identify these patients earlier?
What if we could use short brain scans to quantify cognition at point-of-care clinics for patients at risk of Alzheimer’s? Like an EKG measures the heart under stress, measuring the brain during cognitive tasks provides additional information. A thread 🧵:
November 18, 2024 at 11:55 PM
What if we could use short brain scans to quantify cognition at point-of-care clinics for patients at risk of Alzheimer’s? Like an EKG measures the heart under stress, measuring the brain during cognitive tasks provides additional information. A thread 🧵: